OCI-AML5人急性髓細胞性 返回列表頁

OCI-AML5 人急性髓細胞性白血病細胞
Catalogue No.: C823
Product Format: a 15 ml centrifuge tube
Culture Properties：懸浮
Complete Growth Medium: 89%IMDM+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

191560449-01 （同微-信）


signals, such as the immune checkpoint molecules programpkd death-1 and programpkd deathligａnd 1 (PD-L1). This paper also describes past clinical trials of immunotherapy for patients with GC and details their clinical implications. Strong predictive markers are essential to improve response to immunotherapy. Microsatellite instability, Epstein-Barr virus, PD-L1 expression, and